Direxion Daily S&P Biotech Bear 3X Shares
LABD
LABD
15 hedge funds and large institutions have $28.7M invested in Direxion Daily S&P Biotech Bear 3X Shares in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Holders
15
Holding in Top 10
–
Calls
$7.72M
Puts
$1.49M
Top Buyers
| 1 | +$12.2M | |
| 2 | +$5.55M | |
| 3 | +$509K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$346K |
| 5 |
GS
GTS Securities
New York
|
+$216K |
Top Sellers
| 1 | -$1.71M | |
| 2 | -$1.15M | |
| 3 | -$882K | |
| 4 |
Jane Street
New York
|
-$714K |
| 5 |
QC
Quadrature Capital
London,
United Kingdom
|
-$253K |